"Designing Growth Strategies is in our DNA"

U.S. Influenza Vaccine Market Size, Share & Industry Analysis, By Type (Inactivated, and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Country Forecast, 2024-2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI108130

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Snapshot of Influenza Vaccine Rate
    2. Annual Disease Burden of Influenza
    3. New Product Launches, By Key Players
    4. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    5. Impact of COVID-19 on the Market
  5. U.S. Influenza Vaccine Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. GlaxoSmithKline plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Sanofi
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. AstraZeneca
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. CSL Limited
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. BIKEN Co., Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Abbott
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Viatris Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
    3. Other Prominent Players
Read Less

Figure 1: U.S. Influenza Vaccine Market Revenue Breakdown (USD billion, %), By Type, 2023 & 2032

Figure 2: U.S. Influenza Vaccine Market Value Share (%), by Type, 2023 & 2032

Figure 3: U.S. Influenza Vaccine Market Value Share (%), by Valency, 2023 & 2032

Figure 4: U.S. Influenza Vaccine Market Value Share (%), by Age Group, 2023 & 2032

Figure 5: U.S. Influenza Vaccine Market Value Share (%), by Distribution Channel, 2023 & 2032

Figure 6: U.S. Influenza Vaccine Market Share (%), By Company, 2023

Table 1: U.S. Influenza Vaccine Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 2: U.S. Influenza Vaccine Market Revenue (USD billion) Forecast, by Valency, 2019–2032

Table 3: U.S. Influenza Vaccine Market Revenue (USD billion) Forecast, by Age Group, 2019–2032

Table 4: U.S. Influenza Vaccine Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

U.S. Influenza Vaccine Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 80
Consulting Services
    How will you benefit from our consulting services ?